You will not be allowed to compare more than 4 products at a time
View compareSCREEN DRUG TEST 10 DRUGS DRUG TEST WITH URINE CUP
SCREEN DRUG TEST 10 DRUGS DRUG TEST WITH URINE CUP
Regular price
€18,33 EUR
Sale price
€18,33 EUR
Regular price
€28,00 EUR
Unit price
per
Tax included.
SKU
927972327In stock
Vendor
SCREEN ITALIA SrlDelivery time: 48/72 hours
Free Shipping: Orders over €70
This product page, including its Product Information Leaflet, has been automatically translated.
Description
SCREEN
DRUG TEST
URINE 10
Instructions for use for each test combination of the following drugs: methamphetamine, methadone, amphetamine, barbiturates, tricyclic antidepressants, phencyclidine, cocaine, marijuana, opiates, benzodiazepines.
One-step test for the simultaneous qualitative determination of drugs and their metabolites in human urine.
Precautions
• Product not intended for medical or diagnostic use.
• Do not use beyond the expiration date.
• Store the test strip panel in the sealed pouch until use.
• All samples must be considered potentially hazardous and, therefore, must be handled with precautions related to potentially infectious products.
• After use, the panel must be disposed of according to local regulations in force.
Store in the sealed pouch at a temperature between 2° and 30°C.
The test strip panel is stable until the expiration date indicated on the pouch label.
The test strip panel must be stored in the sealed pouch until use.
Do not freeze.
Do not use beyond the expiration date.
Intended Use and Summary
Screening test for the simultaneous determination of various drugs.
The speed and sensitivity of immunoassay tests have led them to be considered the most accepted as screening tests in urine for the simultaneous detection of drugs of abuse.
The one-step test strip panel (Urine) is a rapid lateral flow immunochromatographic test for the qualitative determination of the following drugs without the aid of instruments:
This test provides only preliminary analytical data.
More specific chemical methods must be used to confirm the analytical result.
Gas chromatography and mass spectrometry (GC/MS) are considered preferential confirmatory methods.
Any result for the determination of the presence of drugs of abuse must be correlated with clinical considerations and professional judgment, particularly when the preliminary result is positive.
Rapid urine screening test that does not require the use of special instruments.
The test uses antibodies to selectively detect high levels of specific substances in human urine.
The residence times are approximate for each substance as they vary depending on frequency of use, body mass, age, health status, drug tolerance, and urine pH.
The product detects the presence of narcotic substances in urine only after their metabolization.
COCAINE (COC)
Cocaine is a potent central nervous system stimulant as well as a local anesthetic derived from the coca plant.
The substance is often self-administered via inhalation or intravenous injection or by smoking the base substance.
AMPHETAMINE (AMP)
Amphetamine is a substance also used for therapeutic purposes.
The substance is often self-administered via inhalation or ingestion.
High doses produce enhanced central nervous system stimulation and induce euphoria, alertness, appetite suppression, increased energy and strength.
More acute reactions produce anxiety, paranoia, hallucinations and psychotic behavior.
METHAMPHETAMINE (MET/MDMA)
Methamphetamine is a potent stimulant chemically related to amphetamine, but with a greater capacity for central nervous system stimulation.
The substance is often self-administered via inhalation, smoking, or ingestion.
MARIJUANA (THC)
Tetrahydrocannabinol is the active ingredient in cannabis.
When smoked or taken orally, THC produces euphoria.
Regular users experience short-term memory impairment and learning delays, and may also have transient episodes of confusion and anxiety.
Relatively heavy long-term use may be associated with behavioral disorders.
OPIATES (OPI)
The opiate class refers to any substance derived from the opium poppy, including natural compounds such as morphine, codeine, and semi-synthetic substances such as heroin.
Opiates act on pain control by depressing the central nervous system.
Withdrawal symptoms may include sweating, tremors, nausea, and irritability.
Opiates can be taken orally or by intravenous, intramuscular, and subcutaneous injection.
Users can also take the substance intravenously or by inhalation.
METHADONE (MTD)
Methadone is a narcotic analgesic prescribed for the treatment of severe to moderate pain and for the treatment of opiate addiction (heroin, Vicodin, Percocet, Morphine).
Methadone is a long-acting analgesic that produces effects lasting from twelve to forty-eight hours.
BARBITURATES (BAR)
Barbiturates are used in medicine as sedatives, hypnotics, and anticonvulsants.
Barbiturates are almost always taken orally in the form of capsules or tablets.
The effects resemble those of alcohol intoxication.
Chronic use of Barbiturates leads to tolerance and physical dependence.
BENZODIAZEPINES (BZO)
Benzodiazepines are frequently prescribed medications for the symptomatic treatment of anxiety and sleep disorders.
They produce their effects through specific receptors involving a neurochemical called gamma-aminobutyric acid (GABA).
Due to their greater safety and efficacy, benzodiazepines have replaced barbiturates in the treatment of anxiety and insomnia.
Benzodiazepines are also used as sedatives before surgical and medical procedures and for the treatment of epileptic seizures and alcohol withdrawal.
PHENCYCLIDINE (PCP)
Phencyclidine, also known as PCP or Angel Dust, is a hallucinogen used in powder, capsule, and tablet form.
The powder is inhaled or smoked after being mixed with marijuana or plant substances.
PCP is commonly administered by inhalation but can also be used intravenously, intranasally, and orally.
Following small doses, users think and act quickly and experience mood alterations from euphoria to depression.
Self-destructive behavior is one of the effects of PCP.
TRICYCLIC ANTIDEPRESSANTS (TCA)
TCAs (tricyclic antidepressants) are commonly used for the treatment of depressive disorders.
TCA overdoses can cause profound depression, cardiotoxicity, and anticholinergic effects.
TCA overdose is the leading cause of drug-related death.
TCAs are taken orally or sometimes by injection.
PRINCIPLE
The one-step test strip panel (Urine) is a rapid immunochromatographic test based on the principle of competitive binding.
Drugs that may be present in the urine sample compete with the corresponding conjugate for the same antibody binding sites.
During the test, a urine sample migrates by capillarity along the membrane.
If a drug is present in the urine sample at a concentration below its cut-off, it will not be able to saturate all the binding sites of the antibody-bound particles present in the strip.
The antibody-bound particles will be captured by the immobilized conjugate, and a visible colored band will appear in the test band region of the corresponding strip.
The colored band will not form in the corresponding area if the drug level is above its cut-off, as all binding sites of the corresponding antibodies will be saturated.
A urine sample positive for the drug being tested will not cause the formation of the colored band due to drug competition, while a urine sample negative for the drug being tested or a sample containing a drug concentration below the cut-off will cause the formation of the colored band in the specific test area.
As a procedural control, a colored band will appear in the control area, indicating that a correct amount of sample has been used and that membrane migration has occurred.
REAGENTS
Each strip of the panel contains mouse monoclonal antibodies bound to particles and the corresponding.
The one-step test strip panel (Urine) is a rapid lateral flow immunochromatographic test conjugated for each drug.
Goat antibodies are used for the control band.
SAMPLE COLLECTION AND PREPARATION
Collect the urine sample in a clean and dry container.
Urine samples collected at any time of the day can be used.
Urine samples with obvious precipitate must be centrifuged, filtered, or allowed to settle to obtain a clear sample for testing.
Urine samples can be stored at 2-8°C for a maximum of 48 hours.
For prolonged storage, samples can be frozen and stored at temperatures below -20°C.
Before using frozen samples, they must be thawed and thoroughly homogenized.
OPERATING PROCEDURE
1. Before opening the pouch, bring it to room temperature.
Remove the product from the pouch and use it as soon as possible.
2. Remove the cap from the strips.
Immerse the product vertically, in the direction of the arrows, into the urine sample for at least 10/15 seconds. Immerse the product up to the level of the wavy lines on the strips but not above them.
3. Replace the cap on the device and place the product horizontally on a flat, non-absorbent surface.
Read the result after 5 minutes.
Do not interpret the result after 10 minutes.
INTERPRETATION OF RESULTS
Negative*: a colored band appears in the control region (C) and a second in the test region (T) for each drug, indicating a negative result.
A negative result indicates that the concentration of the drug in question in the urine is below the detectable cut-off level for that specific drug.
*the shade of color in the test region (T) may vary, but any faint colored band should be considered negative.
Positive: a colored band appears in the control region (C) but not in the test region (T) for each drug, indicating a positive result.
A positive result indicates that the concentration of the drug in question in the urine is above the detectable cut-off level for that specific drug.
Invalid: no control band (C) appears.
The most plausible causes for the absence of the control band may be insufficient sample volume or an incorrect analytical procedure.
Recheck the procedure and repeat the test using a new panel.
If the problem persists, immediately discontinue use of the kit and contact your local distributor.
If the test result is positive, avoid aggressive behavior and calmly seek dialogue with the person concerned.
Consult your doctor, a psychologist, or contact the relevant service in your area.
QUALITY CONTROL
The test includes an internal control system consisting of the red band that appears in the control region (C).
The appearance of this band confirms that the test has been performed correctly with sufficient sample volume, that membrane absorption was adequate, and the procedure was correct.
Standard controls are not provided with the kit; however, it is recommended to test positive and negative controls, as good laboratory practice, to confirm the test procedure and verify its correct characteristics.
LIMITATIONS
The test includes an internal control system consisting of the red band that appears in the control region (C).
The appearance of this band confirms that the test has been performed correctly with sufficient sample volume, that membrane absorption was adequate, and the procedure was correct.
Standard controls are not provided with the kit; however, it is recommended to test positive and negative controls, as good laboratory practice, to confirm the test procedure and verify its correct characteristics.
FORMAT
Kit containing:
• 1 urine container.
• 1 Urine Drug Test 10.
• 1 instruction leaflet.
One-step test for the simultaneous qualitative determination of drugs and their metabolites in human urine.
Precautions
• Product not intended for medical or diagnostic use.
• Do not use beyond the expiration date.
• Store the test strip panel in the sealed pouch until use.
• All samples must be considered potentially hazardous and, therefore, must be handled with precautions related to potentially infectious products.
• After use, the panel must be disposed of according to local regulations in force.
Store in the sealed pouch at a temperature between 2° and 30°C.
The test strip panel is stable until the expiration date indicated on the pouch label.
The test strip panel must be stored in the sealed pouch until use.
Do not freeze.
Do not use beyond the expiration date.
Intended Use and Summary
Screening test for the simultaneous determination of various drugs.
The speed and sensitivity of immunoassay tests have led them to be considered the most accepted as screening tests in urine for the simultaneous detection of drugs of abuse.
The one-step test strip panel (Urine) is a rapid lateral flow immunochromatographic test for the qualitative determination of the following drugs without the aid of instruments:
| Test | Calibrator | Cut-off (ng/ml) |
| Methamphetamine (MET/MDMA) | D-Methamphetamine | 1,000 |
| Methadone (MTD) | Methadone | 300 |
| Amphetamine (AMP) | D-Amphetamine | 1,000 |
| Barbiturates (BAR) | Secobarbital | 300 |
| Tricyclic Antidepressants (TCA) | Nortriptyline | 1,000 |
| Phencyclidine (PCP) | Phencyclidine | 25 |
| Cocaine (COC) | Benzoylecgonine | 300 |
| Marijuana (THC) | 11-nor-Δ9 -THC-9 COOH | 50 |
| Opiates (OPI) | Morphine | 2,000 |
| Benzodiazepines (BZO) | Oxazepam | 300 |
This test provides only preliminary analytical data.
More specific chemical methods must be used to confirm the analytical result.
Gas chromatography and mass spectrometry (GC/MS) are considered preferential confirmatory methods.
Any result for the determination of the presence of drugs of abuse must be correlated with clinical considerations and professional judgment, particularly when the preliminary result is positive.
Rapid urine screening test that does not require the use of special instruments.
The test uses antibodies to selectively detect high levels of specific substances in human urine.
The residence times are approximate for each substance as they vary depending on frequency of use, body mass, age, health status, drug tolerance, and urine pH.
The product detects the presence of narcotic substances in urine only after their metabolization.
COCAINE (COC)
Cocaine is a potent central nervous system stimulant as well as a local anesthetic derived from the coca plant.
The substance is often self-administered via inhalation or intravenous injection or by smoking the base substance.
AMPHETAMINE (AMP)
Amphetamine is a substance also used for therapeutic purposes.
The substance is often self-administered via inhalation or ingestion.
High doses produce enhanced central nervous system stimulation and induce euphoria, alertness, appetite suppression, increased energy and strength.
More acute reactions produce anxiety, paranoia, hallucinations and psychotic behavior.
METHAMPHETAMINE (MET/MDMA)
Methamphetamine is a potent stimulant chemically related to amphetamine, but with a greater capacity for central nervous system stimulation.
The substance is often self-administered via inhalation, smoking, or ingestion.
MARIJUANA (THC)
Tetrahydrocannabinol is the active ingredient in cannabis.
When smoked or taken orally, THC produces euphoria.
Regular users experience short-term memory impairment and learning delays, and may also have transient episodes of confusion and anxiety.
Relatively heavy long-term use may be associated with behavioral disorders.
OPIATES (OPI)
The opiate class refers to any substance derived from the opium poppy, including natural compounds such as morphine, codeine, and semi-synthetic substances such as heroin.
Opiates act on pain control by depressing the central nervous system.
Withdrawal symptoms may include sweating, tremors, nausea, and irritability.
Opiates can be taken orally or by intravenous, intramuscular, and subcutaneous injection.
Users can also take the substance intravenously or by inhalation.
METHADONE (MTD)
Methadone is a narcotic analgesic prescribed for the treatment of severe to moderate pain and for the treatment of opiate addiction (heroin, Vicodin, Percocet, Morphine).
Methadone is a long-acting analgesic that produces effects lasting from twelve to forty-eight hours.
BARBITURATES (BAR)
Barbiturates are used in medicine as sedatives, hypnotics, and anticonvulsants.
Barbiturates are almost always taken orally in the form of capsules or tablets.
The effects resemble those of alcohol intoxication.
Chronic use of Barbiturates leads to tolerance and physical dependence.
BENZODIAZEPINES (BZO)
Benzodiazepines are frequently prescribed medications for the symptomatic treatment of anxiety and sleep disorders.
They produce their effects through specific receptors involving a neurochemical called gamma-aminobutyric acid (GABA).
Due to their greater safety and efficacy, benzodiazepines have replaced barbiturates in the treatment of anxiety and insomnia.
Benzodiazepines are also used as sedatives before surgical and medical procedures and for the treatment of epileptic seizures and alcohol withdrawal.
PHENCYCLIDINE (PCP)
Phencyclidine, also known as PCP or Angel Dust, is a hallucinogen used in powder, capsule, and tablet form.
The powder is inhaled or smoked after being mixed with marijuana or plant substances.
PCP is commonly administered by inhalation but can also be used intravenously, intranasally, and orally.
Following small doses, users think and act quickly and experience mood alterations from euphoria to depression.
Self-destructive behavior is one of the effects of PCP.
TRICYCLIC ANTIDEPRESSANTS (TCA)
TCAs (tricyclic antidepressants) are commonly used for the treatment of depressive disorders.
TCA overdoses can cause profound depression, cardiotoxicity, and anticholinergic effects.
TCA overdose is the leading cause of drug-related death.
TCAs are taken orally or sometimes by injection.
PRINCIPLE
The one-step test strip panel (Urine) is a rapid immunochromatographic test based on the principle of competitive binding.
Drugs that may be present in the urine sample compete with the corresponding conjugate for the same antibody binding sites.
During the test, a urine sample migrates by capillarity along the membrane.
If a drug is present in the urine sample at a concentration below its cut-off, it will not be able to saturate all the binding sites of the antibody-bound particles present in the strip.
The antibody-bound particles will be captured by the immobilized conjugate, and a visible colored band will appear in the test band region of the corresponding strip.
The colored band will not form in the corresponding area if the drug level is above its cut-off, as all binding sites of the corresponding antibodies will be saturated.
A urine sample positive for the drug being tested will not cause the formation of the colored band due to drug competition, while a urine sample negative for the drug being tested or a sample containing a drug concentration below the cut-off will cause the formation of the colored band in the specific test area.
As a procedural control, a colored band will appear in the control area, indicating that a correct amount of sample has been used and that membrane migration has occurred.
REAGENTS
Each strip of the panel contains mouse monoclonal antibodies bound to particles and the corresponding.
The one-step test strip panel (Urine) is a rapid lateral flow immunochromatographic test conjugated for each drug.
Goat antibodies are used for the control band.
SAMPLE COLLECTION AND PREPARATION
Collect the urine sample in a clean and dry container.
Urine samples collected at any time of the day can be used.
Urine samples with obvious precipitate must be centrifuged, filtered, or allowed to settle to obtain a clear sample for testing.
Urine samples can be stored at 2-8°C for a maximum of 48 hours.
For prolonged storage, samples can be frozen and stored at temperatures below -20°C.
Before using frozen samples, they must be thawed and thoroughly homogenized.
OPERATING PROCEDURE
1. Before opening the pouch, bring it to room temperature.
Remove the product from the pouch and use it as soon as possible.
2. Remove the cap from the strips.
Immerse the product vertically, in the direction of the arrows, into the urine sample for at least 10/15 seconds. Immerse the product up to the level of the wavy lines on the strips but not above them.
3. Replace the cap on the device and place the product horizontally on a flat, non-absorbent surface.
Read the result after 5 minutes.
Do not interpret the result after 10 minutes.
INTERPRETATION OF RESULTS
Negative*: a colored band appears in the control region (C) and a second in the test region (T) for each drug, indicating a negative result.
A negative result indicates that the concentration of the drug in question in the urine is below the detectable cut-off level for that specific drug.
*the shade of color in the test region (T) may vary, but any faint colored band should be considered negative.
Positive: a colored band appears in the control region (C) but not in the test region (T) for each drug, indicating a positive result.
A positive result indicates that the concentration of the drug in question in the urine is above the detectable cut-off level for that specific drug.
Invalid: no control band (C) appears.
The most plausible causes for the absence of the control band may be insufficient sample volume or an incorrect analytical procedure.
Recheck the procedure and repeat the test using a new panel.
If the problem persists, immediately discontinue use of the kit and contact your local distributor.
If the test result is positive, avoid aggressive behavior and calmly seek dialogue with the person concerned.
Consult your doctor, a psychologist, or contact the relevant service in your area.
QUALITY CONTROL
The test includes an internal control system consisting of the red band that appears in the control region (C).
The appearance of this band confirms that the test has been performed correctly with sufficient sample volume, that membrane absorption was adequate, and the procedure was correct.
Standard controls are not provided with the kit; however, it is recommended to test positive and negative controls, as good laboratory practice, to confirm the test procedure and verify its correct characteristics.
LIMITATIONS
The test includes an internal control system consisting of the red band that appears in the control region (C).
The appearance of this band confirms that the test has been performed correctly with sufficient sample volume, that membrane absorption was adequate, and the procedure was correct.
Standard controls are not provided with the kit; however, it is recommended to test positive and negative controls, as good laboratory practice, to confirm the test procedure and verify its correct characteristics.
FORMAT
Kit containing:
• 1 urine container.
• 1 Urine Drug Test 10.
• 1 instruction leaflet.